Interestingly, de novo CACNA1A mutations have been recently associated with a sporadic early infantile epileptic encephalopathy (the so-called EIEE42) resulting in a severe clinical phenotype with developmental delay and epilepsy (2). This evidence concerns the gene CACNA1A and epilepsy.